Excess diabetes risk is highest within 2 years of cancer diagnosis.

Antigens raised against human papillomavirus oncogenes HPV-16 and HPV-18.

Study evaluated self-reported data of more than 750K women.

Agent derived from sea sponge may give women a new option.

Responses last for more than a year in heavily pretreated patients.

After definitive therapy fails, surgery is better than systemic chemotherapy.

Few women with BRCA mutations accept guidance for ovarian excision.

No differences in PFS among patients with ovarian cancer.

Patients with MSI-H tumors should be tested for Lynch syndrome regardless of cancer type.

Study highlights the importance of identifying platinum-sensitivity biomarkers.

Niraparib is approved for patients with and without a germline BRCA mutation.

Phase 2 study identifies potential biomarkers for temsirolimus, bevacizumab.

Treatment-free interval and fewer radiographic lesions predict complete resection.

Globally, one woman dies of cervical cancer every two minutes.